Analyst Ratings for Cadrenal Therapeutics (CVKD)

CVKD Rating Summary

CVKD Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CVKD
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: $13.00 (+501.9%) * Over Last 12-Mos
Rating Score: 10 / 10
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/18/2023 Noble Capital Robert LeBoyer New Coverage Outperform
(N/A)
4.00
(N/A)
0.51
(2.16)
323.53% Details
11/20/2023 H.C. Wainwright
» Updated 4/7/2026
Joseph Pantginis New Coverage Buy
(N/A)
13.00
(32.00)
0.47
(2.16)
359.57% Details